CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 48 filers reported holding CONMED CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $461,329 | +5.6% | 374,000 | -2.6% | 0.04% | +5.9% |
| Q4 2022 | $436,992 | -49.5% | 384,000 | -51.1% | 0.03% | -54.1% |
| Q3 2022 | $865,000 | -13.3% | 786,000 | -4.5% | 0.07% | -16.9% |
| Q2 2022 | $998,000 | -30.3% | 823,000 | -1.4% | 0.09% | -16.8% |
| Q1 2022 | $1,431,000 | -9.8% | 835,000 | -12.3% | 0.11% | -7.8% |
| Q4 2021 | $1,587,000 | +2.6% | 952,000 | -4.5% | 0.12% | -7.2% |
| Q3 2021 | $1,547,000 | -6.8% | 997,000 | -2.8% | 0.12% | -3.1% |
| Q2 2021 | $1,660,000 | +0.4% | 1,026,000 | -2.7% | 0.13% | -5.1% |
| Q1 2021 | $1,653,000 | +13.5% | 1,055,000 | +1.6% | 0.14% | +2.3% |
| Q4 2020 | $1,456,000 | +26.9% | 1,038,000 | +1.8% | 0.13% | +1.5% |
| Q3 2020 | $1,147,000 | +40.6% | 1,020,000 | +31.4% | 0.13% | +28.4% |
| Q2 2020 | $816,000 | – | 776,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABSOLUTE INVESTMENT ADVISERS, LLC | 4,115,000 | $4,708,428 | 0.71% |
| ZAZOVE ASSOCIATES LLC | 5,455,000 | $6,306 | 0.58% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,076,000 | $4,644,575 | 0.29% |
| MACKAY SHIELDS LLC | 6,287,000 | $7,123,996 | 0.18% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 15,994,000 | $18,201,172 | 0.13% |
| WOLVERINE ASSET MANAGEMENT LLC | 8,997,000 | $10,397,505 | 0.11% |
| Teton Advisors, Inc. | 350,000 | $404,604 | 0.10% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,264,000 | $3,759,802 | 0.10% |
| Calamos Wealth Management LLC | 384,000 | $436,992 | 0.03% |
| GABELLI FUNDS LLC | 3,000,000 | $3,468,030 | 0.03% |